Cancer Research Targets  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 684-688, February 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catzavelos, C.
Right arrow Articles by Slingerland, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catzavelos, C.
Right arrow Articles by Slingerland, J. M.
[Cancer Research 59, 684-688, February 1, 1999]
© 1999 American Association for Cancer Research


Molecular Biology and Genetics

Reduced Expression of the Cell Cycle Inhibitor p27Kip1 in Non-Small Cell Lung Carcinoma

A Prognostic Factor Independent of Ras1

Charles Catzavelos, Ming-Sound Tsao, Gerrit DeBoer, Nandita Bhattacharya, Frances A. Shepherd and Joyce M. Slingerland2

Departments of Laboratory Medicine and Pathology [M-S. T.] and Medical Oncology [F. S.], Ontario Cancer Institute/Princess Margaret Hospital and The Toronto Hospital, Toronto, Ontario M5G 2M9; Departments of Medical Biophysics [M-S. T., J. M. S., G. D.], Pathology [C. C.], and Cancer Research [J. M. S., N. B.], Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5; and Departments of Medical Oncology [J. M. S.] and Clinical Trials and Epidemiology [G. D.], Toronto-Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario M4N 3M5, Canada

Levels of p27 have been found to have independent prognostic significance in a variety of tumors including breast, colon, prostate, ovary, and gastric carcinomas. We investigated p27 levels and determined rasmutational status in 136 non-small cell lung cancers. We found reduced levels of p27 in 86% of cases and showed a statistically significant inverse correlation between p27 levels and tumor grade. ras mutations were found exclusively in adenocarcinomas and showed no relationship to p27 levels. Clinical data on a subset of the patients studied indicated that all 16 patients who died of disease and 21 of 22 patients who relapsed had low p27 levels, whereas all patients with high p27 levels were alive at la st follow up. These findings suggest that alteration in p27 levels plays an important role in lung tumor progression and that p27 levels may have independent prognostic significance in non-small cell lung cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Liu, S. A. Perdreau, P. Chatterjee, L. Wang, S.-F. Kuan, and A. Duensing
Imatinib Mesylate Induces Quiescence in Gastrointestinal Stromal Tumor Cells through the CDH1-SKP2-p27Kip1 Signaling Axis
Cancer Res., November 1, 2008; 68(21): 9015 - 9023.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C-Q Zhu, W Shih, C-H Ling, and M-S Tsao
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
J. Clin. Pathol., August 1, 2006; 59(8): 790 - 800.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Sonoda, H. Inoue, K. Ogawa, T. Utsunomiya, T.-a. Masuda, and M. Mori
Significance of Skp2 Expression in Primary Breast Cancer
Clin. Cancer Res., February 15, 2006; 12(4): 1215 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. A. Martey, S. J. Pollock, C. K. Turner, K. M. A. O'Reilly, C. J. Baglole, R. P. Phipps, and P. J. Sime
Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L981 - L991.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Osoegawa, I. Yoshino, S. Tanaka, K. Sugio, T. Kameyama, M. Yamaguchi, and Y. Maehara
Regulation of p27 by S-Phase Kinase-Associated Protein 2 Is Associated With Aggressiveness in Non-Small-Cell Lung Cancer
J. Clin. Oncol., October 15, 2004; 22(20): 4165 - 4173.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Q. Zhu, F. H. Blackhall, M. Pintilie, P. Iyengar, N. Liu, J. Ho, T. Chomiak, D. Lau, T. Winton, F. A. Shepherd, et al.
Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker
Clin. Cancer Res., March 15, 2004; 10(6): 1984 - 1991.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wang and M. J. Garabedian
Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1
J. Biol. Chem., December 19, 2003; 278(51): 50897 - 50901.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. J. Moeller, E. D. Head, and R. J. Sheaff
p27Kip1 Inhibition of GRB2-SOS Formation Can Regulate Ras Activation
Mol. Cell. Biol., June 1, 2003; 23(11): 3735 - 3752.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-C. Huang, L.-Y. Chuang, and W.-C. Hung
Mechanisms Underlying Nonsteroidal Anti-Inflammatory Drug-Induced p27Kip1 Expression
Mol. Pharmacol., December 1, 2002; 62(6): 1515 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Yang, G. Ayala, A. D. Marzo, W. Tian, A. Frolov, T. M. Wheeler, T. C. Thompson, and J. W. Harper
Elevated Skp2 Protein Expression in Human Prostate Cancer: Association with Loss of the Cyclin-dependent Kinase Inhibitor p27 and PTEN and with Reduced Recurrence-free Survival
Clin. Cancer Res., November 1, 2002; 8(11): 3419 - 3426.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
W. Kammouni, G. Ramakrishna, G. Sithanandam, G. T. Smith, L. W. Fornwald, A. Masuda, T. Takahashi, and L. M. Anderson
Increased K-Ras Protein and Activity in Mouse and Human Lung Epithelial Cells at Confluence
Cell Growth Differ., September 1, 2002; 13(9): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. McGregor, A. Muntoni, J. Fleming, J. Brown, D. H. Felix, D. G. MacDonald, E. K. Parkinson, and P. R. Harrison
Molecular Changes Associated with Oral Dysplasia Progression and Acquisition of Immortality: Potential for Its Reversal by 5-Azacytidine
Cancer Res., August 15, 2002; 62(16): 4757 - 4766.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. M. Bremnes, R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin
High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non-Small-Cell Lung Cancer
J. Clin. Oncol., May 15, 2002; 20(10): 2417 - 2428.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
Y. A. Elsayed and E. A. Sausville
Selected Novel Anticancer Treatments Targeting Cell Signaling Proteins
Oncologist, December 1, 2001; 6(6): 517 - 537.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W.-C. Hung, H.-C. Chang, M.-R. Pan, T.-H. Lee, and L.-Y. Chuang
Induction of p27KIP1 as a Mechanism Underlying NS398-Induced Growth Inhibition in Human Lung Cancer Cells
Mol. Pharmacol., April 13, 2001; 58(6): 1398 - 1403.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek
Skp2 is oncogenic and overexpressed in human cancers
PNAS, April 12, 2001; (2001) 81474898.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
F. Hommura, H. Dosaka-Akita, T. Mishina, M. Nishi, T. Kojima, H. Hiroumi, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami
Prognostic Significance of p27KIP1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers
Clin. Cancer Res., October 1, 2000; 6(10): 4073 - 4081.
[Abstract] [Full Text]


Home page
JCOHome page
A. M. Oliveira, A. G. Nascimento, S. H. Okuno, and R. V. Lloyd
p27kip1 Protein Expression Correlates With Survival in Myxoid and Round-Cell Liposarcoma
J. Clin. Oncol., August 15, 2000; 18(15): 2888 - 2893.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
A. M. Mirza, A. D. Kohn, R. A. Roth, and M. McMahon
Oncogenic Transformation of Cells by a Conditionally Active Form of the Protein Kinase Akt/PKB
Cell Growth Differ., June 1, 2000; 11(6): 279 - 292.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Nagase, J.-H. Mao, and A. Balmain
A subset of skin tumor modifier loci determines survival time of tumor-bearing mice
PNAS, December 21, 1999; 96(26): 15032 - 15037.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek
Skp2 is oncogenic and overexpressed in human cancers
PNAS, April 24, 2001; 98(9): 5043 - 5048.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.